Skip to main content

Pharmaceutical Packaging Market to reach USD 192.93 billion by 2027 – Report by Market Research Future (MRFR)

New York, June 24, 2021 (GLOBE NEWSWIRE) — Pharmaceutical Packaging Market Overview: According to a comprehensive research report by Market Research Future (MRFR), Pharmaceutical Packaging Market Research Report, Material, Type, Packaging, Application and Region – Forecast till 2027” The global market is projected to reach USD 192.93 billion by 2027 from an estimated USD 107.6 billion in 2020, at a CAGR of 9.21% from 2021 to 2027.

Market Analysis

In the highly competitive pharmaceutical packaging market, rising health awareness and rising demand for convenience necessitate brand enhancement/differentiation through the creation of novel packaging material. In addition, increased environmental concerns and the adoption of new regulatory standards for packaging recycling boost the pharmaceutical packaging industry.

Specific requirements of the elderly and handicapped are being incorporated into packaging design, making the product more user-friendly. Brand protection to prevent counterfeiting is another important factor that boosts market competition.

The development of new packaging types with enhanced features, such as child-resistant packaging (CRP), radio frequency identification technology, and others, has resulted in the market’s rapid rise. Adoption and compliance with regulatory norms in pharmaceutical packaging, as well as standards for packaging recycling, are further propelling the market growth.


Get Free Sample PDF Brochure
https://www.marketresearchfuture.com/sample_request/1291

Emerging markets will play a critical role in the market growth in the future. In several locations, rising populations and attractive demographics serve as growth drivers for the pharmaceutical sector. This presents significant growth potential for prominent pharmaceutical companies dealing with market stagnation, tough regulatory restrictions, and patent expiry.

List of the key players in the worldwide pharmaceutical packaging market profiled are-

  • SCHOTT AG (Germany)
  • Amcor Limited (Australia)
  • Owens-Illinois Inc. (US)
  • Sonoco Products Company (US)
  • WestRock Company (US)
  • West Pharmaceutical Services Inc. (US)
  • CCL Industries Inc. (Canada)
  • AVERY DENNISON CORPORATION (US)
  • Berry Global Inc. (US)
  • International Paper (US)
  • Comar LLC (US)
  • Gerresheimer AG (Germany).

COVID-19 Impact on the Global Pharmaceutical Packaging Market

The pandemic crisis causes a lack of workforce, transportation restrictions, a shortage of raw materials, and the imposition of lockdowns around the world, all of which impede product supply. Furthermore, if these vaccines rely on numerous administration methods (e.g., transdermal, inhaled, oral, and injectable), then demand for primary packaging can be extended across several packaging formats after vaccine approval. As a result, COVID-19 is predicted to drive pharmaceutical packaging growth during the forecast period.


Browse In-depth Market Research Report (272 pages) on Pharmaceutical Packaging 

https://www.marketresearchfuture.com/reports/pharmaceutical-packaging-market-1291


Market Segmentation

The global pharmaceutical packaging industry has been segmented based on material, type, and packaging. 

On the basis of material, the worldwide pharmaceutical packaging market has been segmented into plastic, paper & paperboard, glass, and others. Because of its barrier properties and chemical inertness, the plastic segment is likely to dominate the global market. They can be used to create visually appealing packages that aid in the promotion and marketing of pharmaceutical items.

On the basis of type, the worldwide pharmaceutical packaging market has been segmented into bottles, prefilled syringes, aerosol packs, tubes, blister packs, sachets, parenteral vials & ampoules, caps and closures, and others. The bottles segment is anticipated to hold the maximum market share, owing to the increasing demand for over-the-counter drugs and oral medicines.

On the basis of packaging, the worldwide pharmaceutical packaging market has been segmented into rigid packaging, flexible packaging, and semi-rigid packaging. Due to the protection of the products from biological contamination, physical damage, and external influences that can affect the properties of the products, the rigid packaging segment is predicted to hold the largest market share.

On the basis of application, the worldwide pharmaceutical packaging market has been segmented into generic drugs, nutraceuticals, branded drugs, medical tools & equipment, test kits, and others. The generic drugs segment is estimated to hold the maximum market share. This is due to government officials in places such as North America and the Asia Pacific making efforts to create generic pharmaceuticals with similar active ingredients, strengths, dosages, and routes of administration as a brand-name drug.


Share your Queries
https://www.marketresearchfuture.com/enquiry/1291


Regional Analysis

Region-wise, the global pharmaceutical packaging industry has been segmented into North America, Europe, Asia Pacific, and the rest of the world.

Several significant pharmaceutical packaging firms are headquartered in North America. The presence of global market players increasing their footprint in the region through strategic alliances with raw material suppliers can be linked to the region’s market growth. For example, Hoffmann Neopac AG, a Swiss maker of primary packaging for the pharmaceutical and cosmetics industries, opened a new manufacturing site in the United States in 2018. Furthermore, the regional market’s demand for lightweight and easily transportable packaging is increasing.

In the global pharmaceutical packaging market, Europe had the second greatest market share. The region has created anti-counterfeiting technologies for pharmaceutical packaging, such as overt technology, covert technology, and forensic technology, which improves the region’s current packaging methods and techniques.


To Buy:
https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=1291


Segmentation of Market covered in the research:

Information by Material (Plastic, Paper & Paperboard, Glass), Type (Bottle, Aerosol Pack, Tubes, Blister Pack, Sachets), Packaging (Rigid, Flexible, Semi-rigid), Application (Generic Drugs, Branded Drugs, Medical Tools & Equipment, Test Kits, Nutraceuticals) and Region


About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

CONTACT: Contact:
Market Research Future

Phone:
+1 628 258 0071(US)  
+44 2035 002 764(UK)

Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.